Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
JAK
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
decernotinib
(VX-509) / Vertex
Jyseleca
(filgotinib) / Galapagos, Gilead, SOBI
Jakafi
(ruxolitinib) / Incyte
R 333
/ Rigel
Smyraf
(peficitinib) / Astellas, Maruho
itacitinib
(INCB039110) / Incyte
